Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Gene Alteration-based, Open Label, Multicenter Study of Oral Debio 1347 (CH5183284) in Patients With Advanced Solid Malignancies, Whose Tumours Have an Alteration of the FGFR 1, 2 or 3 Genes

NCT01948297 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.

NCT NCT01948297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01948297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Gene Alteration-based, Open Label, Multicenter Study of Oral Debio 1347 (CH5183284) in Patients With Advanced Solid Malignancies, Whose Tumours Have an Alteration of the FGFR 1, 2 or 3 Genes
Lead sponsor
Debiopharm International SA
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2013
Completion date
June 26, 2020
Enrollment
77 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumours